Putnam Investments LLC Galapagos Nv Transaction History

Putnam Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $2.13 Million - $3.15 Million	-14,579 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $1.3 Million - $1.86 Million	-9,934 Reduced 40.53%	14,579 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $111,450 - $128,930	1,000 Added 4.25%	24,513 $3.16 Million
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $74,465 - $97,875	831 Added 3.66%	23,513 $2.77 Million
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $156,468 - $186,451	1,770 Added 8.46%	22,682 $2.09 Million
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $1.98 Million - $2.51 Million	20,912 New	20,912 $2.09 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.